Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled “Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User — Global Forecast to 2031.”
According to this latest publication from Meticulous Research®, the fill-finish manufacturing market is projected to reach $19.14 billion by 2031, at a CAGR of 9.9% from 2024 to 2031.The growth of this market is driven by the growth of the biopharmaceutical industry, initiatives by pharmaceutical & biopharmaceutical companies to expand their production capacities, advancements in fill-finish manufacturing processes, and the increasing demand for pre-filled syringes. However, high operational costs and challenges in maintaining drug potency throughout the manufacturing process may restrain the market’s growth.
Moreover, initiatives aimed at increasing vaccination rates, increasing focus on biosimilar development, and rising investments in the development of new biologics are expected to create market growth opportunities. However, stringent regulatory requirements governing fill-finish manufacturing and the complexities associated with accurately filling specific medication doses are some of the challenges impeding the market’s growth.
Key Players
The key players operating in the fill-finish manufacturing market are Syntegon Technology GmbH (Germany), Becton, Dickinson and Company (U.S.), Industria Macchine Automatiche S.p.A. (Italy), West Pharmaceutical Services, Inc. (U.S.), Catalent, Inc. (U.S.), AbbVie Inc. (U.S.), Gerresheimer AG (Germany), AptarGroup, Inc. (U.S.), OPTIMA packaging group GmbH (Germany), Baxter International Inc. (U.S.), C.H. Boehringer Sohn AG & Co. KG (Germany), Schott Pharma AG & Co. KGaA (Germany), SGD Pharma (France), and Stevanato Group (Italy).
Fill-finish Manufacturing Market: Future Outlook
The fill-finish manufacturing market is segmented by Offering (Packaging Type [Product {Vials (Liquid Vials, Lyophilized Vials, and Powder Filled Vials), Syringes, Cartridges, Ampoules, and Accessories}, Material {Polymer, Glass, and Other Materials}], Packaging Instruments [System Type {Integrated Systems and Standalone Systems}, Machine Type {Automated Machines and Semi-automated Machines}, and Instrument Type {Processing Instruments and Packaging Instruments (Bottle Filling & Capping Equipment, Blow-Fill-Seal (BFS) Equipment, Aseptic Filling Equipment , Pharmaceutical Spray Filling Equipment, and Other Packaging Instruments)}], and Packaging Services [Vials & Ampoules Filling, Injection Filling, Cartridge Filling, and Other Services]), Formulation (Oral, Parenteral, Topical, and Other Formulations), Sterilization Process (Aseptic Processing and Terminal Sterilization), Application (Biologics [Type {Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, and Gene-Based Biologics} and Development Phase {Clinical/preclinical and Commercial}] and Small Molecules [Clinical/preclinical and Commercial]), End User (Pharmaceutical & Biopharmaceutical Companies, CROs & CDMOs, and Compounding Pharmacies), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Among the offerings covered in this report, in 2024, the packaging type segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to the advancements in fill-finish technology, the increasing demand for injectable and parenteral formulations, the increasing approvals of biologics, the recurring demand for syringes, cartridges, and ampoules, as well as the rising initiatives aimed at increasing vaccination rates. The rising focus on vaccination is driving the demand for vials, consequently increasing the need for fill-finish solutions that ensure contamination-free and efficient filling of vaccines into vials.
Among the formulations covered in this report, in 2024, the parenteral segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to the rising approvals of injectables, growing preference for parenteral administration, increasing demand for parenteral packaging to ensure drug protection & purity, and technological advancements in materials and designs of pre-fillable syringes and vials.
Among the sterilization processes covered in this report, in 2024, the aseptic processing segment is expected to account for the larger share of 60.8% of the fill-finish manufacturing market. This segment’s large market share can be attributed to the rising initiatives aimed at increasing vaccination rates, the increasing demand for biologics, and the growing adoption of aseptic processing due to the need to handle heat-sensitive drugs.
Among the applications covered in this report, the biologics segment is projected to register a higher CAGR of 11.1% during the forecast period. This segment’s growth is driven by factors such as the rising adoption of Bioprocessing 4.0 technologies, government initiatives aimed at promoting biologics development, production capacity expansions by market players, and increasing approvals for biologics.
Among the end users covered in this report, in 2024, the CROs & CDMOs segment is expected to account for the largest share of the fill-finish manufacturing market. This segment’s large market share can be attributed to proliferation of CROs & CDMOs, increasing R&D funds for drug development & manufacturing, strategic partnerships between pharmaceutical companies and CROs & CDMOs, and stringent regulatory requirements governing fill-finish processes
This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Belgium, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
Among the regions covered in this report, Asia-Pacific is projected to register the highest CAGR of 11.3% during the forecast period. The growth of this regional market is driven by the growth of the pharmaceutical market, increasing investments in R&D by pharmaceutical & biopharmaceutical companies, and favorable regulatory policies. The number of new biopharmaceutical companies in China is steadily increasing. Over the past decade (2010-2020), China has witnessed the emergence of more than 140 new biotech firms, bringing the total number of active biopharmaceutical companies in the country to over 500. Additionally, the government is focusing on enhancing production capacities within the biopharmaceutical sector. Such government initiatives are contributing to the market’s growth in Asia-Pacific.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5930
Key questions answered in the report
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
India VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market Worth $ 6.66 Billion by 2030
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More